Atlas Trials

Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.

Clinical trial NCT04122742 · UNKNOWN

Trial details

NCT number
NCT04122742
Sponsor
University Hospital, Bordeaux
Status
UNKNOWN
Study type
OBSERVATIONAL
Rubinstein-Taybi Syndrome
Start date
2019-10-08
Primary completion
2025-10-01
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.